tellurium has been researched along with Colonic-Neoplasms* in 2 studies
2 other study(ies) available for tellurium and Colonic-Neoplasms
| Article | Year |
|---|---|
Shape-Controllable Tellurium-Driven Heterostructures with Activated Robust Immunomodulatory Potential for Highly Efficient Radiophotothermal Therapy of Colon Cancer.
Tellurium (Te)-based semiconductor easily leads to the recombination of photogenerated electron-hole pairs (h Topics: Colonic Neoplasms; Gold; Humans; Immunity; Immunomodulation; Tellurium | 2021 |
The organotelluride catalyst LAB027 prevents colon cancer growth in the mice.
Organotellurides are newly described redox-catalyst molecules with original pro-oxidative properties. We have investigated the in vitro and in vivo antitumoral effects of the organotelluride catalyst LAB027 in a mouse model of colon cancer and determined its profile of toxicity in vivo. LAB027 induced an overproduction of H(2)O(2) by both human HT29 and murine CT26 colon cancer cell lines in vitro. This oxidative stress was associated with a decrease in proliferation and survival rates of the two cell lines. LAB027 triggered a caspase-independent, ROS-mediated cell death by necrosis associated with mitochondrial damages and autophagy. LAB027 also synergized with the cytotoxic drug oxaliplatin to augment its cytostatic and cytotoxic effects on colon cancer cell lines but not on normal fibroblasts. The opposite effects of LAB027 on tumor and on non-transformed cells were linked to differences in the modulation of reduced glutathione metabolism between the two types of cells. In mice grafted with CT26 tumor cells, LAB027 alone decreased tumor growth compared with untreated mice, and synergized with oxaliplatin to further decrease tumor development compared with mice treated with oxaliplatin alone. LAB027 an organotelluride catalyst compound synergized with oxaliplatin to prevent both in vitro and in vivo colon cancer cell proliferation while decreasing the in vivo toxicity of oxaliplatin. No in vivo adverse effect of LAB027 was observed in this model. Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Catalysis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Glutathione; Humans; Hydrogen Peroxide; Mice; Naphthoquinones; Organometallic Compounds; Organoplatinum Compounds; Oxaliplatin; Oxidation-Reduction; Oxidative Stress; Tellurium; Transplantation, Heterologous | 2011 |